Back
Aurinia Pharmaceuticals, Inc. Stock Predictions
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Buy
65
AUPH
Aurinia Pharmaceuticals, Inc.
Last Price:
$14.53
Seasonality Move:
15%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assetsAurinia Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Aurinia Pharmaceuticals, Inc. has on average historically risen by 21.5% based on the past 19 years of stock performance.
-
Aurinia Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
-
Is Aurinia Pharmaceuticals, Inc. Stock Undervalued?The current Aurinia Pharmaceuticals, Inc. [AUPH] share price is $14.86. The Score for AUPH is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
AUPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Aurinia Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Aurinia Pharmaceuticals, Inc. has on average historically risen by 21.5% based on the past 19 years of stock performance.
Aurinia Pharmaceuticals, Inc. Stock Rating
Buy
65
Aurinia Pharmaceuticals, Inc. (AUPH)
is a Buy
Is Aurinia Pharmaceuticals, Inc. overpriced?
-
Aurinia Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Aurinia Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
auriniapharma.com
52-Week Data
52-Week High:
16.54
52-Week Low:
6.55
Prediction Charts
Market Cap:
1.9B
Price in USD:
14.86
Volume:
706.9K
Beta:
3.47
Technical Analysis
SMA50:
15.59
SMA100:
13.93
SMA200:
11.42
52-Wk Change:
92.24%
Stock Predictions
-
Is Aurinia Pharmaceuticals, Inc. stock public?Yes, Aurinia Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Aurinia Pharmaceuticals, Inc. stock quote today?The Aurinia Pharmaceuticals, Inc. stock price is 14.86 USD today.
-
How to buy Aurinia Pharmaceuticals, Inc. stock online?You can buy Aurinia Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 15.90 | 15.35 | 15.97 | 15.01 |
| Jan-5 | 15.17 | 15.30 | 15.36 | 14.82 |
| Jan-6 | 15.42 | 15.44 | 15.71 | 15.32 |
| Jan-7 | 15.69 | 16.02 | 16.05 | 15.42 |
| Jan-8 | 15.90 | 15.33 | 16.19 | 15.15 |
| Jan-9 | 15.37 | 15.15 | 15.61 | 15.13 |
| Jan-12 | 15.18 | 15.28 | 15.32 | 14.98 |
| Jan-13 | 15.23 | 14.99 | 15.28 | 14.75 |
| Jan-14 | 15.00 | 15.23 | 15.23 | 14.76 |
| Jan-15 | 15.25 | 14.87 | 15.28 | 14.74 |
| Jan-16 | 14.78 | 14.85 | 15.08 | 14.78 |
| Jan-20 | 14.39 | 14.79 | 14.82 | 14.36 |
| Jan-21 | 14.86 | 14.78 | 14.95 | 14.59 |
| Jan-22 | 14.81 | 14.86 | 15.19 | 14.80 |
Aurinia Pharmaceuticals, Inc. Earnings
Aurinia Pharmaceuticals, Inc. Earnings Report: Per Share Aurinia Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aurinia Pharmaceuticals, Inc. Forecast Revenue Growth
Aurinia Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Aurinia Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.14 per share.
* Aurinia Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.